Perrigo Recalls Clindamycin and Benzoyl Peroxide Gel Due to Mold
L. Perrigo Company is recalling 162,534 tubes of Clindamycin Phosphate and Benzoyl Peroxide Gel because a small number of tubes may contain mold on the cap.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that could cause temporary or medically reversible adverse health consequences. The hazard is limited to mold on the cap of a non-sterile product, with no reported illnesses or injuries.
Plain-English summary
L. Perrigo Company is voluntarily recalling 162,534 tubes of Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g. The product is a prescription-only topical gel manufactured in Israel and distributed nationwide in the United States.
The recall was initiated due to microbial contamination of the non-sterile product. Specifically, a small number of tubes may include the presence of mold on the cap. The affected product is identified by NDC 45802-736-84 and UPC 345802736840. Specific lot codes and expiration dates are listed in the official recall notice.
Consumers and healthcare providers should stop using the recalled product and return it to the pharmacy or point of purchase for a refund or replacement. Patients should consult their healthcare provider for alternative treatment options if necessary.
The recalled product
- Product
- CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN, BENZOYL PEROXIDE)
- Brand
- CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
- Manufacturer
- L. Perrigo Company
- Category
- Drug — Topical Prescription
- Affected units
- 162,534
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 345802736840
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · L. Perrigo Company
See all →- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Antihistamine Tablets Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateClindamycin and Benzoyl Peroxide Gel Recalled for Superpotent Formulation
FDA (Drugs) · 2021-12-22
- ModeratePerrigo Recalls Clindamycin Oral Solution Due to Particulate Matter
FDA (Drugs) · 2014-03-26
- ModerateCardinal Health Recalls Benzoyl Peroxide Gel Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- SevereSynergy Rx Recalls CLEAR Gel Due to Sterility Assurance Concerns
FDA (Drugs) · 2017-03-22
- SevereSynergy Rx Recalls Benzoyl Peroxide and Clindamycin Due to Sterility Concerns
FDA (Drugs) · 2017-03-22
- ModerateBenzoyl peroxide cream recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-03